Table 1.
Univariate analysis of potential risk factors for IT as first event after UDCA prescription (using Cox' model) at first presentation.
Fig 1.
Liver histologies of PSC patients with a mHAI score greater and lower than 3 points.
A: typical concentric fibrosis and low grade of inflammation. B: typical periductular fibrosis and additionally signs of interface hepatitis (*), representing a patient with a mHAI score of 8/18. Staining: hematoxylin eosin.
Table 2.
Histological characteristics in patients with and without IT.
Table 3.
Histological disease activity and simplified AIH score as single risk factors for IT in patients with PSC.
Table 4.
Laboratory values at the time of PSC diagnosis and the association with the subsequent introduction of IT during the course of PSC.
Fig 2.
Cumulative probability of introduction of IT in the presence of competing risks at the time of PSC diagnosis (start of UDCA prescription): Alkaline phosphatase (AP), bilirubin, alanine aminotransferase (ALT), immunoglobulin G (IgG).